Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Cancer Research UK
Cancer Research UK
Cancer Research UK
Cancer Research UK
Cancer Research UK
Stanford University
Blueprint Medicines Corporation
BeiGene
DNAtrix, Inc.